CDC Panel Considers Pfizer Boosters for 12- to 15-Year-Olds

CDC Panel Considers Pfizer Boosters for 12- to 15-Year-Olds

This post was originally published on this siteAdolescents could gain access to the shots for the first time as the Omicron variant spreads through communities and threatens to disrupt schools trying to stay open.

Read more
Pfizer antiviral reduces hospitalization, death among high-risk people by 89%, study shows: COVID-19 updates

Pfizer antiviral reduces hospitalization, death among high-risk people by 89%, study shows: COVID-19 updates

This post was originally published on this siteA study found that Pfizer’s antiviral drug, Paxlovid, reduced hospitalization or death among high-risk people by 89%. More COVID-19 updates.     

Read more
‘Our best defense’: Pfizer says third dose of its COVID vaccine protects against omicron

‘Our best defense’: Pfizer says third dose of its COVID vaccine protects against omicron

This post was originally published on this siteA third dose of the Pfizer-BioNTech vaccine appears to be as effective against omicron as two doses were against the original variant.     

Read more
Pfizer Says Vaccine Loses Effectiveness Against Omicron

Pfizer Says Vaccine Loses Effectiveness Against Omicron

This post was originally published on this sitePfizer and BioNTech said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.

Read more
COVID booster doses could be authorized by Friday, ‘should be a priority’ for US adults, experts say

COVID booster doses could be authorized by Friday, ‘should be a priority’ for US adults, experts say

This post was originally published on this siteThe CDC has said it’s safe to mix vaccine brands, and data suggests Pfizer-BioNTech or Moderna would be more protective than a second J&J shot.     

Read more
Pfizer Says Covid-19 Pill Is 89% Effective in Study

Pfizer Says Covid-19 Pill Is 89% Effective in Study

This post was originally published on this siteThe drug company plans to seek FDA authorization of a treatment that patients could take at home to keep them out of the hospital.

Read more
F.D.A. Expected to Clear Pfizer Coronavirus Vaccine for Young Children

F.D.A. Expected to Clear Pfizer Coronavirus Vaccine for Young Children

This post was originally published on this siteExperts said the shot could bring relief to parents anxious about their children getting sick, though some worry that those most at risk may slip through the cracks.

Read more
States prepare to receive pediatric Pfizer doses ahead of full approval for ages 5-11: Live COVID-19 updates

States prepare to receive pediatric Pfizer doses ahead of full approval for ages 5-11: Live COVID-19 updates

This post was originally published on this siteStates including Washington and Indiana are expecting to receive hundreds of thousands of pediatric doses of Pfizer’s vaccine next week. Live updates.     

Read more
US to weigh authorizing Pfizer Covid vaccine for younger children

US to weigh authorizing Pfizer Covid vaccine for younger children

This post was originally published on this site A high-level medical panel of US government advisors will meet Tuesday to decide whether to authorize the Pfizer Covid-19 vaccine for children aged five to 11 years old. If, as is widely expected, the independent experts convened by the Food and Drug...

Read more
FDA Review of Pfizer Covid-19 Vaccine for Kids Expected

FDA Review of Pfizer Covid-19 Vaccine for Kids Expected

This post was originally published on this siteU.S. health regulators are expected to weigh in soon on the evidence for giving the Pfizer-BioNTech Covid-19 vaccine to children 5 to 11 years old.

Read more